Who is sponsoring NCT04575909?

NCT04575909 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT04575909?

Interventions in NCT04575909: Aprosodia Intervention, No-Intervention.

What condition does NCT04575909 study?

NCT04575909 studies Right Hemispheric Stroke.

Is NCT04575909 still recruiting?

NCT04575909 is currently withdrawn. Last updated 20 March 2024.

Last reviewed 2024-03-20 · How we verify

NCT04575909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional Connectivity and Predictors of Affective Aprosodia Intervention in Subacute Right Hemisphere Stroke

Withdrawn NA Last updated 20 March 2024

What this trial tests

NA trial testing Aprosodia Intervention in Right Hemispheric Stroke. Withdrawn.

Timeline

1 February 2021

Primary endpoint
19 March 2024

19 March 2024

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Start date	1 February 2021
Primary completion	19 March 2024
Estimated completion	19 March 2024
Sites	1 location across United States

Drugs / interventions tested

Aprosodia Intervention
No-Intervention

Conditions studied

Right Hemispheric Stroke — all drugs for Right Hemispheric Stroke →

Sponsor

Johns Hopkins University

Who can join

Adults 18 to 89, any sex, with Right Hemispheric Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is an investigation of a behavioral speech and language treatment for emotional prosody recognition and production deficits in subacute right hemisphere stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reversing the Ruin: Rehabilitation, Recovery, and Restoration After Stroke.
Stockbridge MD, Bunker LD, Hillis AE. · · 2022 · cited 6× · PMID 36181577 · DOI 10.1007/s11910-022-01231-5

Verify or expand the search:

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04575909 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 20 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04575909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing